Your shopping cart is currently empty

VZ185 is a potent, fast-acting, and selective von Hippel–Lindau–based dual degrader probe targeting BRD9 and BRD7 with DC50 values of 4.5 nM and 1.8 nM, respectively. VZ185 displays marked cytotoxicity in EOL-1 and A-402 cell lines with EC50 values of 3 nM and 40 nM, enabling advanced studies of chromatin remodeling, targeted protein degradation, and cancer cell dependency on SWI/SNF complex components.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $136 | - | In Stock | |
| 5 mg | $289 | - | In Stock | |
| 10 mg | $396 | - | In Stock | |
| 25 mg | $787 | - | In Stock | |
| 50 mg | $1,190 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $533 | - | In Stock |
| Description | VZ185 is a potent, fast-acting, and selective von Hippel–Lindau–based dual degrader probe targeting BRD9 and BRD7 with DC50 values of 4.5 nM and 1.8 nM, respectively. VZ185 displays marked cytotoxicity in EOL-1 and A-402 cell lines with EC50 values of 3 nM and 40 nM, enabling advanced studies of chromatin remodeling, targeted protein degradation, and cancer cell dependency on SWI/SNF complex components. |
| Targets&IC50 | BRD9:1.8 nM(DC), BRD7:4.5 nM(DC) |
| In vitro | In biochemical assays, VZ185 functioned as a dual degrader recruiting VHL E3 ligase, exhibiting DC50 values of 1.8 nM for BRD9 and 4.5 nM for BRD7. In cellular assays utilizing human cancer cell lines EOL-1 and A-204, the compound mediated BRD9 degradation with DC50 values ranging from 2 to 8 nM while maintaining stability in plasma and microsomes [1]. |
| Synonyms | VZ-185, VZ 185 |
| Molecular Weight | 995.21 |
| Formula | C53H67FN8O8S |
| Cas No. | 2306193-61-1 |
| Smiles | CN1C=C(C=2C(C1=O)=CN=CC2)C3=CC(OC)=C(CN4CCN(CCCCCOC5=C(CNC(=O)[C@H]6N(C([C@@H](NC(=O)C7(F)CC7)C(C)(C)C)=O)C[C@H](O)C6)C=CC(=C5)C=8SC=NC8C)CC4)C(OC)=C3 |
| Relative Density. | 1.34 g/cm3 (Predicted) |
| Storage | store at low temperature | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 160 mg/mL (160.77 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.